Bronchoalveolar lavage (BAL) samples were available from 21 COVID-19 ICU patients, 3 of whom had detectable serum IFN-α2 Abs (2 neutralizing, 1 non-neutralizing). The gene discussed is IFNA2; the disease is COVID-19.